NCT06716606: A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- State
- Under way
- Phase
- Phase 3
- People
- 514 planned
- Started
- 12 Dec 2024
- Primary completion
- 27 Sep 2030
- Arms
- Participants receiving Belimumab
- Results
- None posted
- 4 Dec 2024: Trial registered
- 12 Dec 2024: Trial started